Global Benfotiamine Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Benfotiamine

• 1.1 Definition of Benfotiamine
• 1.2 Benfotiamine Segment by Type
  • 1.2.1 Global Benfotiamine Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Low Purity
  • 1.2.3 High Purity
• 1.3 Benfotiamine Segment by Applications
  • 1.3.1 Global Benfotiamine Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Dietary Supplement
  • 1.3.3 Diabetic Neuropathy
  • 1.3.4 Others
• 1.4 Global Benfotiamine Overall Market
  • 1.4.1 Global Benfotiamine Revenue (2014-2025)
  • 1.4.2 Global Benfotiamine Production (2014-2025)
  • 1.4.3 North America Benfotiamine Status and Prospect (2014-2025)
  • 1.4.4 Europe Benfotiamine Status and Prospect (2014-2025)
  • 1.4.5 China Benfotiamine Status and Prospect (2014-2025)
  • 1.4.6 Japan Benfotiamine Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Benfotiamine Status and Prospect (2014-2025)
  • 1.4.8 India Benfotiamine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Benfotiamine
• 2.3 Manufacturing Process Analysis of Benfotiamine
• 2.4 Industry Chain Structure of Benfotiamine

3 Development and Manufacturing Plants Analysis of Benfotiamine

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Benfotiamine Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Benfotiamine
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Benfotiamine Production and Capacity Analysis
• 4.2 Benfotiamine Revenue Analysis
• 4.3 Benfotiamine Price Analysis
• 4.4 Market Concentration Degree

5 Benfotiamine Regional Market Analysis

• 5.1 Benfotiamine Production by Regions
  • 5.1.1 Global Benfotiamine Production by Regions
  • 5.1.2 Global Benfotiamine Revenue by Regions
• 5.2 Benfotiamine Consumption by Regions
• 5.3 North America Benfotiamine Market Analysis
  • 5.3.1 North America Benfotiamine Production
  • 5.3.2 North America Benfotiamine Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Benfotiamine Import and Export
• 5.4 Europe Benfotiamine Market Analysis
  • 5.4.1 Europe Benfotiamine Production
  • 5.4.2 Europe Benfotiamine Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Benfotiamine Import and Export
• 5.5 China Benfotiamine Market Analysis
  • 5.5.1 China Benfotiamine Production
  • 5.5.2 China Benfotiamine Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Benfotiamine Import and Export
• 5.6 Japan Benfotiamine Market Analysis
  • 5.6.1 Japan Benfotiamine Production
  • 5.6.2 Japan Benfotiamine Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Benfotiamine Import and Export
• 5.7 Southeast Asia Benfotiamine Market Analysis
  • 5.7.1 Southeast Asia Benfotiamine Production
  • 5.7.2 Southeast Asia Benfotiamine Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Benfotiamine Import and Export
• 5.8 India Benfotiamine Market Analysis
  • 5.8.1 India Benfotiamine Production
  • 5.8.2 India Benfotiamine Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Benfotiamine Import and Export

6 Benfotiamine Segment Market Analysis (by Type)

• 6.1 Global Benfotiamine Production by Type
• 6.2 Global Benfotiamine Revenue by Type
• 6.3 Benfotiamine Price by Type

7 Benfotiamine Segment Market Analysis (by Application)

• 7.1 Global Benfotiamine Consumption by Application
• 7.2 Global Benfotiamine Consumption Market Share by Application (2014-2019)

8 Benfotiamine Major Manufacturers Analysis

• 8.1 Klaire
  • 8.1.1 Klaire Benfotiamine Production Sites and Area Served
  • 8.1.2 Klaire Product Introduction, Application and Specification
  • 8.1.3 Klaire Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Hamari
  • 8.2.1 Hamari Benfotiamine Production Sites and Area Served
  • 8.2.2 Hamari Product Introduction, Application and Specification
  • 8.2.3 Hamari Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 BioXera Pharma
  • 8.3.1 BioXera Pharma Benfotiamine Production Sites and Area Served
  • 8.3.2 BioXera Pharma Product Introduction, Application and Specification
  • 8.3.3 BioXera Pharma Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Kaival Chemicals
  • 8.4.1 Kaival Chemicals Benfotiamine Production Sites and Area Served
  • 8.4.2 Kaival Chemicals Product Introduction, Application and Specification
  • 8.4.3 Kaival Chemicals Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Kimia Biosciences
  • 8.5.1 Kimia Biosciences Benfotiamine Production Sites and Area Served
  • 8.5.2 Kimia Biosciences Product Introduction, Application and Specification
  • 8.5.3 Kimia Biosciences Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 AOR
  • 8.6.1 AOR Benfotiamine Production Sites and Area Served
  • 8.6.2 AOR Product Introduction, Application and Specification
  • 8.6.3 AOR Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Country Life
  • 8.7.1 Country Life Benfotiamine Production Sites and Area Served
  • 8.7.2 Country Life Product Introduction, Application and Specification
  • 8.7.3 Country Life Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Neurohacker Collective
  • 8.8.1 Neurohacker Collective Benfotiamine Production Sites and Area Served
  • 8.8.2 Neurohacker Collective Product Introduction, Application and Specification
  • 8.8.3 Neurohacker Collective Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 XY Mogen
  • 8.9.1 XY Mogen Benfotiamine Production Sites and Area Served
  • 8.9.2 XY Mogen Product Introduction, Application and Specification
  • 8.9.3 XY Mogen Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Prayosha Health Care
  • 8.10.1 Prayosha Health Care Benfotiamine Production Sites and Area Served
  • 8.10.2 Prayosha Health Care Product Introduction, Application and Specification
  • 8.10.3 Prayosha Health Care Benfotiamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Mascot
• 8.12 Pharmaffiliates
• 8.13 Hangzhou Eastbiopharm
• 8.14 Basil Pharmaceuticals
• 8.15 Ami Lifesciences

9 Development Trend of Analysis of Benfotiamine Market

• 9.1 Global Benfotiamine Market Trend Analysis
  • 9.1.1 Global Benfotiamine Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Benfotiamine Regional Market Trend
  • 9.2.1 North America Benfotiamine Forecast 2019-2025
  • 9.2.2 Europe Benfotiamine Forecast 2019-2025
  • 9.2.3 China Benfotiamine Forecast 2019-2025
  • 9.2.4 Japan Benfotiamine Forecast 2019-2025
  • 9.2.5 Southeast Asia Benfotiamine Forecast 2019-2025
  • 9.2.6 India Benfotiamine Forecast 2019-2025
• 9.3 Benfotiamine Market Trend (Product Type)
• 9.4 Benfotiamine Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Benfotiamine Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List